Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication March 10, 2006
- Accepted for publication March 10, 2006
- Published online April 26, 2006.
Copyright & Usage
© 2006 by Society of Nuclear Medicine
Author Information
Statistics from Altmetric.com
Cited By...
Article usage
Jump to section
Related Articles
Cited By...
- ImmunoPET imaging of LAG-3 expression in tumor microenvironment with 68Ga-labelled cyclic peptides tracers: from bench to bedside
- 68Ga-NC-BCH Whole-Body PET Imaging Rapidly Targets Claudin18.2 in Lesions in Gastrointestinal Cancer Patients
- Importance of Blood Glucose Management Before 18F-FDG PET/CT in 322 Patients with Bacteremia of Unknown Origin
- Whole-Body Parametric Imaging of 18F-FDG PET Using uEXPLORER with Reduced Scanning Time
- First-in-Humans Evaluation of a PD-L1-Binding Peptide PET Radiotracer in Non-Small Cell Lung Cancer Patients
- Immune Checkpoint Inhibitor-Related Adverse Effects and 18F-FDG PET/CT Findings
- Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
- Effects of Repeated 131I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors
- Establishment of National DRL for CT in Hybrid Imaging Studies (The Second Phase of the National NM CT (PET) Dose Audit for Kuwait Population -2019)
- SNMMI Procedure Standard/EANM Practice Guideline on Pediatric 18F-FDG PET/CT for Oncology 1.0
- Impact of FDG PET Imaging for Expanding Patient Eligibility and Measuring Treatment Response in a Genome-Driven Basket Trial of the Pan-HER Kinase Inhibitor, Neratinib
- Assessing the Effect of Various Blood Glucose Levels on 18F-FDG Activity in the Brain, Liver, and Blood Pool
- Progressive cranial neuropathy and uterine involvement in myeloid sarcoma
- Is True Whole-Body 18F-FDG PET/CT Required in Pediatric Lymphoma? An IAEA Multicenter Prospective Study
- Prognostic Value of Deep Learning PET/CT-Based Radiomics: Potential Role for Future Individual Induction Chemotherapy in Advanced Nasopharyngeal Carcinoma
- Use of a Qualification Phantom for PET Brain Imaging in a Multicenter Consortium: A Collaboration Between the Pediatric Brain Tumor Consortium and the SNMMI Clinical Trials Network
- An International Survey on Clinical Reporting of PET/CT Examinations: A Starting Point for Cross-Specialty Engagement
- An International Survey of PET/CT Clinical Reporting
- Biodistribution, Tumor Detection, and Radiation Dosimetry of 18F-5-Fluoro-2'-Deoxycytidine with Tetrahydrouridine in Solid Tumors
- Validation of Metabolically Active Tumor Volume and Total Lesion Glycolysis as 18F-FDG PET/CT-derived Prognostic Biomarkers in Chemorefractory Metastatic Colorectal Cancer
- A Postreconstruction Harmonization Method for Multicenter Radiomic Studies in PET
- Metabolic heterogeneity on baseline 18FDG-PET/CT scan is a predictor of outcome in primary mediastinal B-cell lymphoma
- Novel Method to Detect and Characterize 18F-FDG Infiltration at the Injection Site: A Single-Institution Experience
- 18F-Tetrafluoroborate, a PET Probe for Imaging Sodium/Iodide Symporter Expression: Whole-Body Biodistribution, Safety, and Radiation Dosimetry in Thyroid Cancer Patients
- Incidence of Brain Metastases on Follow-up 18F-FDG PET/CT Scans of Non-Small Cell Lung Cancer Patients: Should We Include the Brain?
- Joint SNMMI-ASNC Expert Consensus Document on the Role of 18F-FDG PET/CT in Cardiac Sarcoid Detection and Therapy Monitoring
- Quantitative Accuracy and Lesion Detectability of Low-Dose 18F-FDG PET for Lung Cancer Screening
- Does PET SUV Harmonization Affect PERCIST Response Classification?
- PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII
- Positron Emission Mammography Image Interpretation for Reduced Image Count Levels
- Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies
- Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy
- Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma
- Reduction of Patient Anxiety in PET/CT Imaging by Improving Communication Between Patient and Technologist
- The importance of harmonizing interim positron emission tomography in non-Hodgkin lymphoma: focus on the Deauville criteria
- 64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer
- Prospective Study of Tailoring Whole-Body Dual-Modality [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography With Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging
- Elevated 18F-FDG Levels in Blood and Organs After Angiotensin II Receptor Blocker Administration: Experiment in Mice Administered Telmisartan
- Beta-2 Microglobulin as a Diagnostic Parameter in Non-Hodgkin Lymphoma: A Comparative Study with FDG-PET
- SNMMI/ASNC/SCCT Guideline for Cardiac SPECT/CT and PET/CT 1.0
- Reporting Guidance for Oncologic 18F-FDG PET/CT Imaging
- EANM/SNMMI Guideline for 18F-FDG Use in Inflammation and Infection
- Clinical Utility of 18F-FDG Positron Emission Tomography and Computed Tomography in Patients With Suspected Cardiovascular Implantable Electronic Device Infection
- Imaging of Multiple Myeloma and Related Plasma Cell Dyscrasias
- Need for Standardization of 18F-FDG PET/CT for Treatment Response Assessments
- Effect of Patient Arm Motion in Whole-Body PET/CT
- Shortened Dynamic 18F-FDG PET
- Could Different Hydration Protocols Affect the Quality of 18F-FDG PET/CT Images?
- Patient Weight-Based Acquisition Protocols to Optimize18F-FDG PET/CT Image Quality
- Changes in 18F-Fluorodeoxyglucose and 18F-Fluorodeoxythymidine Positron Emission Tomography Imaging in Patients with Non-Small Cell Lung Cancer Treated with Erlotinib
- Preliminary Study of 11C-Choline PET/CT for T Staging of Locally Advanced Nasopharyngeal Carcinoma: Comparison with 18F-FDG PET/CT
- Variations in Clinical PET/CT Operations: Results of an International Survey of Active PET/CT Users
- Standardization of Quantitative Imaging: The Time Is Right, and 18F-FDG PET/CT Is a Good Place to Start
- Whole-Body 18F-FDG PET/CT: The Need for a Standardized Field of View--A Referring-Physician Aid
- Do Hyperglycemia and Diabetes Affect the Incidence of False-Negative 18F-FDG PET/CT Studies in Patients Evaluated for Infection or Inflammation and Cancer? A Comparative Analysis
- The Twilight Saga of Insulin Administration in Hyperglycemic Patients Undergoing 18F-FDG PET
- Reply: The Twilight Saga of Insulin Administration in Hyperglycemic Patients Undergoing 18F-FDG PET
- Odontogenic myxofibroma synchronous with primary angiosarcoma of the spleen
- Expert Opinions on Positron Emission Tomography and Computed Tomography Imaging in Lymphoma
- Comparison of Imaging Protocols for 18F-FDG PET/CT in Overweight Patients: Optimizing Scan Duration Versus Administered Dose
- Standards for PET Image Acquisition and Quantitative Data Analysis
- Prospective Evaluation of Physiologic Uptake Detected with True Whole-Body 18F-FDG PET/CT in Healthy Subjects
- Impact of Intravenous Insulin on 18F-FDG PET in Diabetic Cancer Patients
- The Effect of Renal Failure on 18F-FDG Uptake: A Theoretic Assessment
- The role of clinical imaging in oncological drug development
- Contrast-Enhanced 18F-FDG PET/CT: 1-Stop-Shop Imaging for Assessing the Resectability of Pancreatic Cancer
- Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors
- Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma